212 related articles for article (PubMed ID: 1356617)
1. Cyclophosphamide resistance in medulloblastoma.
Friedman HS; Colvin OM; Kaufmann SH; Ludeman SM; Bullock N; Bigner DD; Griffith OW
Cancer Res; 1992 Oct; 52(19):5373-8. PubMed ID: 1356617
[TBL] [Abstract][Full Text] [Related]
2. Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines.
Peters RH; Jollow DJ; Stuart RK
Cancer Res; 1991 May; 51(10):2536-41. PubMed ID: 2021933
[TBL] [Abstract][Full Text] [Related]
3. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard.
Evans CG; Bodell WJ; Tokuda K; Doane-Setzer P; Smith MT
Cancer Res; 1987 May; 47(10):2525-30. PubMed ID: 2882834
[TBL] [Abstract][Full Text] [Related]
4. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
Xu BH; Gupta V; Singh SV
Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448
[TBL] [Abstract][Full Text] [Related]
5. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
Lau DH; Lewis AD; Ehsan MN; Sikic BI
Cancer Res; 1991 Oct; 51(19):5181-7. PubMed ID: 1717140
[TBL] [Abstract][Full Text] [Related]
6. Melphalan transport, glutathione levels, and glutathione-S-transferase activity in human medulloblastoma.
Friedman HS; Skapek SX; Colvin OM; Elion GB; Blum MR; Savina PM; Hilton J; Schold SC; Kurtzberg J; Bigner DD
Cancer Res; 1988 Oct; 48(19):5397-402. PubMed ID: 3416297
[TBL] [Abstract][Full Text] [Related]
7. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.
Cole SP; Downes HF; Mirski SE; Clements DJ
Mol Pharmacol; 1990 Feb; 37(2):192-7. PubMed ID: 1968221
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.
Kable EP; Favier D; Parsons PG
Cancer Res; 1989 May; 49(9):2327-31. PubMed ID: 2706620
[TBL] [Abstract][Full Text] [Related]
9. The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide.
Bacolod MD; Lin SM; Johnson SP; Bullock NS; Colvin M; Bigner DD; Friedman HS
Curr Cancer Drug Targets; 2008 May; 8(3):172-9. PubMed ID: 18473730
[TBL] [Abstract][Full Text] [Related]
10. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
[TBL] [Abstract][Full Text] [Related]
11. Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide.
Crook TR; Souhami RL; Whyman GD; McLean AE
Cancer Res; 1986 Oct; 46(10):5035-8. PubMed ID: 3463410
[TBL] [Abstract][Full Text] [Related]
12. Identification of glutathione S-transferase as a determinant of 4-hydroperoxycyclophosphamide resistance in human breast cancer cells.
Chen G; Waxman DJ
Biochem Pharmacol; 1995 May; 49(11):1691-701. PubMed ID: 7786310
[TBL] [Abstract][Full Text] [Related]
13. Repair analysis of 4-hydroperoxycyclophosphamide-induced DNA interstrand crosslinking in the c-myc gene in 4-hydroperoxycyclophosphamide-sensitive and -resistant medulloblastoma cell lines.
Dong Q; Bullock N; Ali-Osman F; Colvin OM; Bigner DD; Friedman HS
Cancer Chemother Pharmacol; 1996; 37(3):242-46. PubMed ID: 8529284
[TBL] [Abstract][Full Text] [Related]
14. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer.
Berger SJ; Gosky D; Zborowska E; Willson JK; Berger NA
Cancer Res; 1994 Aug; 54(15):4077-83. PubMed ID: 8033140
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.
Green JA; Vistica DT; Young RC; Hamilton TC; Rogan AM; Ozols RF
Cancer Res; 1984 Nov; 44(11):5427-31. PubMed ID: 6488194
[TBL] [Abstract][Full Text] [Related]
16. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
[TBL] [Abstract][Full Text] [Related]
17. Hepsulfam sensitivity in human breast cancer cell lines: the role of glutathione and glutathione S-transferase in resistance.
Armstrong DK; Gordon GB; Hilton J; Streeper RT; Colvin OM; Davidson NE
Cancer Res; 1992 Mar; 52(6):1416-21. PubMed ID: 1540950
[TBL] [Abstract][Full Text] [Related]
18. Glutathione related enzymes in cis-diamminedichloroplatinum (II)-sensitive and-resistant human ovarian carcinoma cells.
Oguchi H; Kikkawa F; Kojima M; Maeda O; Mizuno K; Suganuma N; Kawai M; Tomoda Y
Anticancer Res; 1994; 14(1A):193-200. PubMed ID: 7909418
[TBL] [Abstract][Full Text] [Related]
19. Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells.
Lutzky J; Astor MB; Taub RN; Baker MA; Bhalla K; Gervasoni JE; Rosado M; Stewart V; Krishna S; Hindenburg AA
Cancer Res; 1989 Aug; 49(15):4120-5. PubMed ID: 2568167
[TBL] [Abstract][Full Text] [Related]
20. Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferase.
Friedman HS; Pegg AE; Johnson SP; Loktionova NA; Dolan ME; Modrich P; Moschel RC; Struck R; Brent TP; Ludeman S; Bullock N; Kilborn C; Keir S; Dong Q; Bigner DD; Colvin OM
Cancer Chemother Pharmacol; 1999; 43(1):80-5. PubMed ID: 9923545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
